• Je něco špatně v tomto záznamu ?

Cardiovascular effects of flavonoids are not caused only by direct antioxidant activity

P. Mladenka, L. Zatloukalová, T. Filipský, R. Hrdina,

. 2010 ; 49 (6) : 963-975. [pub] 20100611

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, práce podpořená grantem, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/bmc12026931

Epidemiological, as well as most in vivo, studies suggest that flavonoids have a positive influence on various cardiovascular diseases. Traditionally, these effects were only attributed to their antioxidant activity, which has been extensively studied. Apart from the direct antioxidant properties, which include direct reactive oxygen species scavenging activity and transient metal chelation, this review reports on many other effects that in pharmacologically achievable concentrations may also be responsible for their positive cardiovascular influence. These include direct inhibition of some radical-forming enzymes (xanthine oxidase, NADPH oxidase, and lipoxygenases), decreased platelet aggregation and leukocyte adhesion, and vasodilatory properties. For each of the aforementioned effects different structural features are necessary. Briefly, a catecholic B-ring is necessary for scavenging activity; hydroxyl groups in an ortho position, the 3-hydroxy-4-keto group, or the 5-hydroxy-4-keto group enable iron chelation; planar conformation with the 4-keto group and 2,3-double bond is essential for inhibition of leukocyte adhesion and platelet aggregation; specific hydroxy-methoxy ortho conformation in ring B is necessary for the inhibition of NADPH oxidase; and the 4-keto group is a requisite for vasodilatory action. This review shows that positive cardiovascular effects of flavonoids are achieved by various flavonoids via the interaction with different targets.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc12026931
003      
CZ-PrNML
005      
20160323095250.0
007      
ta
008      
120816s2010 xxu f 000 0#eng||
009      
AR
024    7_
$a 10.1016/j.freeradbiomed.2010.06.010 $2 doi
035    __
$a (PubMed)20542108
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Mladěnka, Přemysl $u Department of Pharmacology and Toxicology, Faculty of Pharmacy, Charles University in Prague, Heyrovskeho 1203, 500 05 Hradec Králové, Czech Republic. mladenkap@faf.cuni.cz $7 xx0233006
245    10
$a Cardiovascular effects of flavonoids are not caused only by direct antioxidant activity / $c P. Mladenka, L. Zatloukalová, T. Filipský, R. Hrdina,
520    9_
$a Epidemiological, as well as most in vivo, studies suggest that flavonoids have a positive influence on various cardiovascular diseases. Traditionally, these effects were only attributed to their antioxidant activity, which has been extensively studied. Apart from the direct antioxidant properties, which include direct reactive oxygen species scavenging activity and transient metal chelation, this review reports on many other effects that in pharmacologically achievable concentrations may also be responsible for their positive cardiovascular influence. These include direct inhibition of some radical-forming enzymes (xanthine oxidase, NADPH oxidase, and lipoxygenases), decreased platelet aggregation and leukocyte adhesion, and vasodilatory properties. For each of the aforementioned effects different structural features are necessary. Briefly, a catecholic B-ring is necessary for scavenging activity; hydroxyl groups in an ortho position, the 3-hydroxy-4-keto group, or the 5-hydroxy-4-keto group enable iron chelation; planar conformation with the 4-keto group and 2,3-double bond is essential for inhibition of leukocyte adhesion and platelet aggregation; specific hydroxy-methoxy ortho conformation in ring B is necessary for the inhibition of NADPH oxidase; and the 4-keto group is a requisite for vasodilatory action. This review shows that positive cardiovascular effects of flavonoids are achieved by various flavonoids via the interaction with different targets.
650    _2
$a zvířata $7 D000818
650    _2
$a antioxidancia $x farmakologie $x terapeutické užití $7 D000975
650    _2
$a kardiovaskulární nemoci $x farmakoterapie $x patofyziologie $7 D002318
650    _2
$a buněčná adheze $x účinky léků $7 D002448
650    _2
$a enzymová indukce $x účinky léků $7 D004790
650    _2
$a flavonoidy $x chemie $x farmakologie $x terapeutické užití $7 D005419
650    _2
$a lidé $7 D006801
650    _2
$a aktivace trombocytů $x účinky léků $7 D015539
650    _2
$a vztahy mezi strukturou a aktivitou $7 D013329
650    _2
$a vazodilatace $x účinky léků $7 D014664
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
655    _2
$a přehledy $7 D016454
700    1_
$a Zatloukalová, Libuše $7 xx0113003
700    1_
$a Filipský, Tomáš $7 _AN077685
700    1_
$a Hrdina, Radomír $7 xx0077249
773    0_
$w MED00001857 $t Free radical biology & medicine $x 1873-4596 $g Roč. 49, č. 6 (2010), s. 963-975
856    41
$u https://pubmed.ncbi.nlm.nih.gov/20542108 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y m $z 0
990    __
$a 20120816 $b ABA008
991    __
$a 20160323095318 $b ABA008
999    __
$a ok $b bmc $g 948973 $s 784277
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2010 $b 49 $c 6 $d 963-975 $e 20100611 $i 1873-4596 $m Free radical biology & medicine $n Free Radic Biol Med $x MED00001857
LZP    __
$b NLK113 $a Pubmed-20120816/11/01

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...